EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine HCl): Technical Application Guide

What This Product Solves

EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride, CAS 25952-53-8) addresses a critical need for water-soluble and efficient carboxyl group activation in aqueous or mixed-solvent environments. As a representative water-soluble carbodiimide reagent, EDC.HCl is routinely employed as a peptide synthesis coupling reagent, bioconjugation reagent, and nucleotide synthesis reagent. Its primary utility lies in catalyzing amide bond formation between carboxyl and primary amine groups, enabling the synthesis of peptides, protein conjugates, and nucleic acid derivatives under conditions where organic-soluble carbodiimides are unsuitable or incompatible. The reagent’s solubility in water, DMSO, and ethanol facilitates direct use in diverse in vitro biochemical workflows where rapid, controlled bond formation is essential.

EDC.HCl is not suitable for in vivo or clinical workflows, as there are currently no supporting data for such applications. Its use is restricted to research protocols in controlled laboratory settings.

For a broader overview, see the Technical Workflow Guide, which details in vitro peptide synthesis and bioconjugation contexts, and the Technical Guide for nucleotide coupling and related protocols.

Protocol Parameters

• Solubility in water | ≥39 mg/mL | Product prep and direct aqueous workflows | Ensures sufficient reagent concentration for standard peptide and bioconjugation reactions without pre-dissolution in organic solvents | Product dossier
• Storage temperature | -20°C (solid, desiccated) | Long-term stock stability | Prevents hydrolysis and degradation of dry reagent, preserving coupling efficiency over time | Product dossier
• Working solution stability | Prepare fresh; avoid long-term storage | Routine workflow | EDC.HCl solutions are prone to hydrolysis; fresh preparation is recommended to maintain reactivity | Product dossier
• Quantitative monitoring | Spectrophotometric methods | QC, process control | Enables assessment of reagent integrity or reaction progress without chromatographic separation | Product dossier
• Solubility in DMSO/ethanol | ≥19.2 mg/mL (DMSO), ≥39.6 mg/mL (ethanol) | Mixed-solvent protocols | Allows flexibility in coupling protocols involving co-solvents or solubilization of hydrophobic partners | Product dossier

Workflow Setup and QC Checklist

Successful use of EDC.HCl as an amide bond formation reagent requires attention to workflow parameters that influence coupling efficiency, specificity, and downstream product quality:

1. Reagent Preparation: Dissolve EDC.HCl in ultrapure water (or suitable co-solvent) immediately before use to minimize hydrolysis. Typical working concentrations align with the upper solubility limits (e.g., up to 39 mg/mL in water).
2. Buffer Selection: Use buffers that do not contain primary amines (e.g., avoid Tris), as these can react with activated intermediates. MES or phosphate buffers are preferred for most aqueous coupling workflows.
3. Reactant Stoichiometry: Employ a slight excess of EDC.HCl relative to carboxyl-containing substrate to ensure complete activation. For peptide synthesis and bioconjugation, a 1.2–2-fold molar excess is commonly applied, but individual protocol optimization is recommended.
4. Mixing and Reaction Time: Initiate mixing rapidly after EDC.HCl addition. Monitor reaction progress as desired, using spectrophotometric or other quantitative methods for quality control, as recommended for this product.
5. Byproduct Removal: Following coupling, remove the urea byproduct by dialysis, precipitation, or chromatography, depending on the scale and application.
6. QC Verification: Confirm amide bond formation or conjugation by SDS-PAGE, HPLC, or mass spectrometry as appropriate.

Common Failure Modes and Fixes

• Hydrolysis of EDC.HCl: If coupling efficiency drops, verify that EDC.HCl was prepared fresh and that solutions were not stored for extended periods. Hydrolysis leads to inactive reagent and poor yields. Always prepare solutions immediately prior to use.
• Incompatible buffer system: Avoid buffers with primary amine groups (e.g., Tris, glycine). Use amine-free buffers such as MES or phosphate to prevent competitive side reactions.
• Incomplete activation or coupling: If product formation is suboptimal, check reactant stoichiometry and ensure a sufficient excess of EDC.HCl is present. Consider the addition of N-hydroxysuccinimide (NHS) or sulfo-NHS to stabilize the activated intermediate if extended reaction times are necessary.
• Precipitation or solubility issues: For poorly soluble substrates, dissolve EDC.HCl in DMSO or ethanol within the documented solubility limits to facilitate homogeneous reaction mixtures.
• High background or side-product formation: Monitor reaction time and temperature; excessive reaction times or elevated temperatures can increase side reactions. Optimize these parameters based on empirical observation.

Scope and Limitations

EDC.HCl is validated as an in vitro amide bond formation reagent for peptide synthesis, bioconjugation, and nucleotide coupling workflows. It is also suitable for esterification and lactonization reactions in biochemical protocols. No in vivo or clinical data are available, and the reagent is not intended for therapeutic or diagnostic use in humans or animals. Its compatibility with aqueous and mixed-solvent systems makes it a versatile choice for laboratory protocols, but care must be taken to avoid hydrolysis and inappropriate buffer systems.

The Technical Guide further discusses in vitro coupling workflows, while the Protocol and Workflow Guidance covers activation of carboxyl groups for amide bond formation in detail.

Conclusion

EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) offers a reliable, water-soluble option for controlled amide bond formation in peptide synthesis and bioconjugation workflows. Adherence to recommended preparation, storage, and workflow protocols is essential for optimal results. For further product details and ordering information, see the APExBIO product page. This reagent should be used exclusively for in vitro research applications and is not supported for in vivo or clinical use.